Literature DB >> 24408114

A randomized trial of hemodiafiltration and change in cardiovascular parameters.

Irina M Mostovaya1, Michiel L Bots, Marinus A van den Dorpel, Muriel P C Grooteman, Otto Kamp, Renée Levesque, Piet M Ter Wee, Menso J Nubé, Peter J Blankestijn.   

Abstract

BACKGROUND AND
OBJECTIVE: Increased left ventricular mass (LVM), low ventricular ejection fraction (EF), and high pulse-wave velocity (PWV) relate to overall and cardiovascular mortality in patients with ESRD. The aim of this study was to determine the effect of online hemodiafiltration (HDF) versus low-flux hemodialysis (HD) on LVM, EF, and PWV. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Echocardiography was used to assess LVM and EF in 342 patients in the CONvective TRAnsport STudy followed for up to 4 years. PWV was measured in 189 patients for up to 3 years. Effect of HDF versus HD on LVM, EF, and PWV was evaluated using linear mixed models.
RESULTS: Patients had a mean age of 63 years, and 61% were male. At baseline, median LVM was 227 g (interquartile range [IQR], 183-279 g), and median EF was 65% (IQR, 55%-72%). Median PWV was 9.8 m/s (IQR, 7.5-12.0 m/s). There was no significant difference between the HDF and HD treatment groups in rate of change in LVM (HDF: change, -0.9 g/yr [95% confidence interval (95% CI), -8.9 to 7.7 g]; HD: change, 12.5 g/yr [95% CI, -3.0 to 27.5 g]; P for difference=0.13), EF (HDF: change, -0.3%/yr [95% CI, -2.3% to 1.8%]; HD: change, -3.4%/yr [95% CI, -5.9% to -0.9%]; P=0.17), or PWV (HDF: change, -0.0 m/s per year [95% CI, -0.4 to 0.4 m/s); HD: change, 0.0 m/s per year [95% CI, -0.3 to 0.2 m/s]; P=0.89). No differences in rate of change between treatment groups were observed for subgroups of age, sex, residual kidney function, dialysis vintage, history of cardiovascular disease, diabetes, or convection volume.
CONCLUSIONS: Treatment with online HDF did not affect changes in LVM, EF, or PWV over time compared with HD.

Entities:  

Keywords:  cardiovascular; ejection fraction; hemodialysis; left ventricular mass; pulse-wave velocity

Mesh:

Year:  2014        PMID: 24408114      PMCID: PMC3944767          DOI: 10.2215/CJN.07140713

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  30 in total

1.  Bias in meta-analysis and funnel plot asymmetry.

Authors:  M Biljana; M Jelena; J Branislav; R Milorad
Journal:  Stud Health Technol Inform       Date:  1999

2.  Arterial stiffness in postmenopausal women: determinants of pulse wave velocity.

Authors:  Corinne E I Lebrun; Yvonne T van der Schouw; Annette A A Bak; Frank H de Jong; Huibert A P Pols; Diederick E Grobbee; Steven W J Lamberts; Michiel L Bots
Journal:  J Hypertens       Date:  2002-11       Impact factor: 4.844

3.  Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease.

Authors:  Lawrence P McMahon; Simon D Roger; Adeera Levin
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

4.  Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.

Authors:  Carmine Zoccali; Francesco A Benedetto; Francesca Mallamaci; Giovanni Tripepi; Giuseppe Giacone; Benedetta Stancanelli; Alessandro Cataliotti; Lorenzo S Malatino
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

5.  Noninvasive determination of age-related changes in the human arterial pulse.

Authors:  R Kelly; C Hayward; A Avolio; M O'Rourke
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

6.  Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy.

Authors:  Helmut Schiffl; Susanne M Lang; Rainald Fischer
Journal:  Int Urol Nephrol       Date:  2012-12-07       Impact factor: 2.370

Review 7.  The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

Authors:  Jonathan Himmelfarb; Peter Stenvinkel; T Alp Ikizler; Raymond M Hakim
Journal:  Kidney Int       Date:  2002-11       Impact factor: 10.612

8.  Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.

Authors:  A K Cheung; M J Sarnak; G Yan; J T Dwyer; R J Heyka; M V Rocco; B P Teehan; A S Levey
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

Review 9.  Traditional and emerging cardiovascular risk factors in end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi
Journal:  Kidney Int Suppl       Date:  2003-06       Impact factor: 10.545

10.  Echocardiographic detection of pressure-overload left ventricular hypertrophy: effect of criteria and patient population.

Authors:  R B Devereux; P N Casale; I W Hammond; D D Savage; M H Alderman; E Campo; D R Alonso; J H Laragh
Journal:  J Clin Hypertens       Date:  1987-03       Impact factor: 3.738

View more
  10 in total

1.  Changes in Cardiac Output and Perfusion during Hemodialysis and Hemodiafiltration Treatments Determined by Cardiac Magnetic Resonance Imaging.

Authors:  Peter J Blankestijn; Andrew Davenport
Journal:  J Am Soc Nephrol       Date:  2017-02-09       Impact factor: 10.121

Review 2.  Why choose high volume online post-dilution hemodiafiltration?

Authors:  Carlo Basile; Andrew Davenport; Peter J Blankestijn
Journal:  J Nephrol       Date:  2016-09-01       Impact factor: 3.902

3.  The first year on haemodialysis: a critical transition.

Authors:  Natascha J H Broers; Anne C M Cuijpers; Frank M van der Sande; Karel M L Leunissen; Jeroen P Kooman
Journal:  Clin Kidney J       Date:  2015-04-07

4.  A Systematic Review and Meta-analysis of Nonpharmacologic-based Interventions for Aortic Stiffness in End-Stage Renal Disease.

Authors:  Rosendo A Rodriguez; Richard Hae; Matthew Spence; Beverley Shea; Mohsen Agharazii; Kevin D Burns
Journal:  Kidney Int Rep       Date:  2019-05-22

5.  Evolution of high-sensitivity troponin-T and echocardiography parameters in patients undergoing high efficiency on-line hemodiafiltration versus conventional low-flux hemodialysis.

Authors:  Isabelle Ethier; Dominique Auger; Martin Beaulieu; Ewa Wesolowska; Renée Lévesque
Journal:  PLoS One       Date:  2019-10-22       Impact factor: 3.240

6.  Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis.

Authors:  Kevin C Maki; Meredith L Wilcox; Mary R Dicklin; Rahul Kakkar; Michael H Davidson
Journal:  BMC Nephrol       Date:  2022-01-16       Impact factor: 2.388

7.  CONVINCE in the context of existing evidence on haemodiafiltration.

Authors:  Robin W M Vernooij; Michiel L Bots; Giovanni F M Strippoli; Bernard Canaud; Krister Cromm; Mark Woodward; Peter J Blankestijn
Journal:  Nephrol Dial Transplant       Date:  2022-05-25       Impact factor: 7.186

8.  High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.

Authors:  Marijke Dekker; Andreas Pasch; Frank van der Sande; Constantijn Konings; Matthias Bachtler; Mauro Dionisi; Matthias Meier; Jeroen Kooman; Bernard Canaud
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240

9.  Vasoactive Peptide Levels after Change of Dialysis Mode.

Authors:  Fredrik Uhlin; Ingegerd Odar-Cederlöf; Elvar Theodorsson; Anders Fernström
Journal:  Nephron Extra       Date:  2015-10-28

Review 10.  Clinical evidence on haemodiafiltration.

Authors:  Peter J Blankestijn; Muriel P Grooteman; Menso J Nube; Michiel L Bots
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.